Source: GlobeNewswire

Press Release: NeuroStar : Neuronetics Announces Preliminary Fourth Quarter and Full Year Revenue

Preliminary full year 2018 total revenue of approximately $52.8 million, an increase of approximately 31% over the full year 2017, exceeding previously issued guidance

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from NeuroStar's latest SEC filings

Annual Revenue

Based on data from NeuroStar's latest SEC filings

Employees

Christopher Thatcher's photo - President & CEO of NeuroStar

President & CEO

Christopher Thatcher

CEO Approval Rating

80/100

NeuroStar focuses on developing and commercializing non-invasive therapies for the treatment of chronic psychiatric and ... Read more